Host-Microbe-Diet Interactions in Ageing
Lead Research Organisation:
MRC London Institute of Medical Sciences
Abstract
Centenarians are the fastest growing age group in the UK. The major burden of disability and ill-health in developed countries falls on older people as medical advances are not sufficient to maintain people healthier for longer. This incurs important medical, economic and social costs to societies barely coping with an ageing demographic. Ageing is modulated by genetics and its constant evolving environment. It has been found that body health during ageing is strongly affected by the symbiotic microbes that inhabit the gut. However, the understanding of how microbes affect the functions of the host biology is still in its infancy. This is where the use of model organisms such as nematode worms come into play. These models allow us to tease apart the complex interactions between host genetics, gut microbes and nutrition in a way that no other models can. They also provide a platform to prove mechanistic causation between interventions, such as nutrients or drugs, and allow scientists to build mathematical and computational models that can be used for the translation of this information to application in humans. Ultimately, the findings of this programme will inform on how to harness gut microbes to improve late life health.
Technical Summary
Animals rarely live in isolation, but rather exist in intimate association with other species, particularly microorganisms. The microbiota and its genes play key roles in human health and disease. Recently, several reports have linked the role of microbiota with organismal ageing. Not only the composition and function of the microbiota changes over time within an ageing organism but also the function of the microbiota can modulate organismal ageing. Yet, the causal mechanisms regulating this intertwined and complex communication remain widely unexplored and ill-defined. Despite great advances in our understanding of ageing biology from a genomic-centric approach, we do not fully comprehend why similar mutations or treatments lead to a wide-range of host phenotypes in a context-dependent manner. Nutrition and the microbiome are two key environmental factors regulating host physiology. Chemical elements originating from these exogenous sources are the cornerstone of life as they offer a source of energy, the building blocks for cellular construction and the micronutrients which are essential for the adequate functioning of cells. Importantly, the microbiome is significantly enriched for genes involved in the metabolism of dietary compounds to produce molecules of biological relevance. These metabolites may explain the present gaps in our knowledge coupling the gut microbiota to biological host mechanisms in health and disease throughout life. The overarching goal of this programme is to unravel the molecular basis of microbial and dietary-induced host metabolic-rewiring during ageing. Here, we integrate novel experimental designs to build mechanistic in silico models through systems biology approaches in order to predictively understand the contribution of diet in the regulation of host biology through or independently of the microbiome. The underlying mechanisms will be studied using the powerful genetic, microbiota and ageing model Caenorhabditis elegans, which mirrors many conserved human metabolic pathways and allows for a well-defined control of environmental cues. This interdisciplinary programme will combine state-of-the-art high-throughput screening host- microbe- diet approaches developed in the Cabreiro lab and combined omics approaches at the host and microbial level to identify and characterize: microbially-regulated host metabolic pathways regulating ageing (Aim 1); identify dietary and microbial metabolites critical for healthy ageing (Aim 2); and microbial-diet -interactions regulating metabolism and host ageing (Aim 3). Ultimately, we aim at demonstrating the power of interspecies predictive models and the possibility of creating precise genetic interventions in bacteria for discovering and harnessing new metabolites with important implications in regulating healthy ageing.
Publications

Mkrtchyan GV
(2020)
ARDD 2020: from aging mechanisms to interventions.
in Aging

Rutter J
(2019)
Detecting Changes in the Caenorhabditis elegans Intestinal Environment Using an Engineered Bacterial Biosensor
in ACS Synthetic Biology

Bjedov I
(2020)
Fine-tuning autophagy maximises lifespan and is associated with changes in mitochondrial gene expression in Drosophila
in PLOS Genetics

Pryor R
(2019)
Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy.
in Cell

Essmann CL
(2020)
Mechanical properties measured by atomic force microscopy define health biomarkers in ageing C. elegans.
in Nature communications

Bana B
(2019)
The Microbiome and Aging.
in Annual review of genetics

Pryor R
(2020)
The Role of the Microbiome in Drug Response.
in Annual review of pharmacology and toxicology
Description | Investigating the role of the metformin resistome on host health |
Amount | £1,747,775 (GBP) |
Funding ID | 102531/Z/13/A |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 10/2018 |
End | 02/2022 |
Title | 4-way high-throughput screening approaches |
Description | We have developed a novel high-throughput method that allows us to investigate the role of nutrients on the mode of action of diverse therapeutic drugs on host physiology in a microbiome dependent manner |
Type Of Material | Model of mechanisms or symptoms - non-mammalian in vivo |
Year Produced | 2019 |
Provided To Others? | Yes |
Impact | High impact publication: Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. Pryor R, Norvaisas P, Marinos G, Best L, Thingholm LB, Quintaneiro LM, De Haes W, Esser D, Waschina S, Lujan C, Smith RL, Scott TA, Martinez-Martinez D, Woodward O, Bryson K, Laudes M, Lieb W, Houtkooper RH, Franke A, Temmerman L, Bjedov I, Cochemé HM, Kaleta C, Cabreiro F. Cell. 2019 Sep 5;178(6):1299-1312.e29. doi: 10.1016/j.cell.2019.08.003. Epub 2019 Aug 29. |
URL | https://www.cell.com/cell/fulltext/S0092-8674(19)30891-8 |
Title | Atomic force microscopy in ageing C. elegans |
Description | We have adapted atomic force microscopy to investigate ageing biomarkers in a model organism |
Type Of Material | Model of mechanisms or symptoms - non-mammalian in vivo |
Year Produced | 2020 |
Provided To Others? | Yes |
Impact | We have discovered genetic, pharmacological and nutritional interventions that improve healthy ageing. |
URL | https://www.nature.com/articles/s41467-020-14785-0 |
Title | Live microbiome biosensors |
Description | We have developed in vivo microbiome biosensors |
Type Of Material | Biological samples |
Year Produced | 2019 |
Provided To Others? | Yes |
Impact | We have shown that we can use bacteria as sensors of the metabolic environment in the gut. |
URL | http://pubs.acs.org/doi/10.1021/acssynbio.9b00166 |
Description | Alexis Barr |
Organisation | Imperial College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Discovery of novel prokaryotic metabolite regulating cancer therapy |
Collaborator Contribution | Validation of a prokaryotic metabolite on human cancer cell lines |
Impact | The is a multi-disciplinary collaboration between a model organism lab (ours) and a human cell cycle lab (Alexis Barr) |
Start Year | 2019 |
Description | Christoph Kaletta |
Organisation | University of Kiel |
Country | Germany |
Sector | Academic/University |
PI Contribution | We are the leading lab studying the role of microbes on the effect of the antidiabetic drug metformin on host physiology |
Collaborator Contribution | The partner provided computational expertise and analysed human patient microbiome data to investigate whether the gut microbiota in humans is rewired to produce a metabolite by metformin. |
Impact | Publications: Rosina Pryor *,1,2,3, Povilas Norvaisas *,3, Christoph Kaleta*,4, Leonor Quintaneiro 1,2,3, Wouter De Haes 5, Celia Lujan 6, Reuben L. Smith 7, Timothy Scott 3, Daniel Martinez-Martinez, 1,2, Orla Woodward 3, Kevin Bryson 8, Riekelt H. Houtkooper 6, Liesbet Temmerman 4, Ivana Bjedov 5, Helena M. Cochemé 1,2 and Filipe Cabreiro. In revision at Cell |
Start Year | 2018 |
Description | Helena Cocheme |
Organisation | Medical Research Council (MRC) |
Department | MRC Clinical Sciences Centre (CSC) |
Country | United Kingdom |
Sector | Public |
PI Contribution | Leading lab studying the role of anti-diabetic drugs, microbiota and host regulation |
Collaborator Contribution | The partner provided support by studying evolutionarily conserved mechanisms found in our lab in another model organism- Drosophila melanogaster |
Impact | Publications: Rosina Pryor *,1,2,3, Povilas Norvaisas *,3, Christoph Kaleta*,4, Leonor Quintaneiro 1,2,3, Wouter De Haes 5, Celia Lujan 6, Reuben L. Smith 7, Timothy Scott 3, Daniel Martinez-Martinez, 1,2, Orla Woodward 3, Kevin Bryson 8, Riekelt H. Houtkooper 6, Liesbet Temmerman 4, Ivana Bjedov 5, Helena M. Cochemé 1,2 and Filipe Cabreiro. In revision at Cell |
Start Year | 2016 |
Description | Ivana Bjedov |
Organisation | University College London |
Department | UCL Cancer Institute |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Leading lab studying the role of antidiabetic drugs on microbes and host physiology |
Collaborator Contribution | The partner provided expertise on drosophila and performed experimental work to validate some of our findings |
Impact | Publications: Rosina Pryor *,1,2,3, Povilas Norvaisas *,3, Christoph Kaleta*,4, Leonor Quintaneiro 1,2,3, Wouter De Haes 5, Celia Lujan 6, Reuben L. Smith 7, Timothy Scott 3, Daniel Martinez-Martinez, 1,2, Orla Woodward 3, Kevin Bryson 8, Riekelt H. Houtkooper 6, Liesbet Temmerman 4, Ivana Bjedov 5, Helena M. Cochemé 1,2 and Filipe Cabreiro. In revision at Cell |
Start Year | 2015 |
Description | Microbiome talk for the general public |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | 50 General practitioners/lay public attended a public engagement event that focused on the role of the microbiome in health and disease. It generated questions and discussion. |
Year(s) Of Engagement Activity | 2019 |